LH vs REPL · P/E 23, rev $13.01B vs $825.7M cap
Laboratory Corporation of America Holdings (LH) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported LH revenue for 2024-12-31 was $13.01B. Net income was $747.1M. Revenue was up 7.0% from 2023-12-31 to 2024-12-31. LH currently screens at market cap $21.07B and trailing P/E 22.8.
REPL does not have a complete income-statement cache yet.
LH currently screens at market cap $21.07B and trailing P/E 22.8. REPL currently screens at market cap $825.7M.
Not investment advice. Open the LH and REPL stock pages for the full models.
Not investment advice.